Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study

Tripodi, 2011, Antiphospholipid syndrome. laboratory detection, mechanisms of action and treatment, J Intern Med, 270, 110, 10.1111/j.1365-2796.2011.02362.x

Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x

Pengo, 2009, Update of the guidelines for lupus anticoagulant detection, J Thromb Haemost, 7, 1737, 10.1111/j.1538-7836.2009.03555.x

Rosner, 1987, Detection and quantitative evaluation of lupus circulating anticoagulant activity, Thromb Haemost, 57, 144, 10.1055/s-0038-1651083

Tripodi, 2002, Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA, Thromb Haemost, 88, 583, 10.1055/s-0037-1613259

Tripodi, 2003, Lupus anticoagulant(LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity‐purified immunoglobulin with LA activity, Clin Chem, 49, 1608, 10.1373/49.10.1608

Jennings, 1997, Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation, Thromb Haemost, 77, 934, 10.1055/s-0038-1656080

Brandt, 1991, Effect of lupus anticoagulants on the activated partial thromboplastin time: results of the College of American Pathologists survey program, Arch Pathol Lab Med, 115, 109

Roussi, 1996, Lupus anticoagulants: first French interlaboratory Etalonorm survey, Am J Clin Pathol, 105, 788, 10.1093/ajcp/105.6.788

Favaloro, 2005, Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of the Australasia Quality Assurance Programs for Hematology, Sem Thromb Hemost, 31, 49, 10.1055/s-2005-863805

Favaloro, 2006, Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multicenter evaluation, Thromb Haemost, 96, 73, 10.1160/TH06-01-0004

Arnout, 1999, Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2‐glycoprotein I, Thromb Haemost, 81, 929, 10.1055/s-0037-1614601

Pengo, 2007, Survey on lupus anticoagulant diagnosis by central evaluation of positive plasma samples, J Thromb Haemost, 5, 925, 10.1111/j.1538-7836.2007.02454.x

Tripodi, 2007, Laboratory testing for lupus anticoagulants: a review of issues affecting results, Clin Chem, 53, 1629, 10.1373/clinchem.2007.089524

Pradella, 2013, Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays, Clin Chem Lab Med, 51, 379, 10.1515/cclm-2012-0382

Gardiner, 2000, The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant, Br J Haematol, 111, 1230, 10.1111/j.1365-2141.2000.02466.x

Tripodi, 2011, Standardization of lupus anticoagulant. feasibility study of a calibration model to minimize between‐method variability, Thromb Res, 127, 589, 10.1016/j.thromres.2011.01.015

Pengo, 2007, A comparison of lupus anticoagulant‐positive patients with clinical picture of antiphospholipid syndrome and those without, Arterioscler Thromb Vasc Biol, 27, e309, 10.1161/ATVBAHA.107.153536

Horowitz GL, Altaie S, Boyd JC, Ceriotti F, Garg U, Horn P, Pesce A, Sine HE, Zakowski J. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline‐third edition. CLSI Document C28‐A3; Clinical and Laboratory Standards Institute, Wayne PA, Vol 28, Number 30, 2008.